Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$0.42 - $0.72 $748,013 - $1.28 Million
-1,780,985 Reduced 22.38%
6,177,962 $3.89 Million
Q3 2023

Nov 14, 2023

BUY
$0.6 - $1.53 $232,778 - $593,584
387,964 Added 5.12%
7,958,947 $4.78 Million
Q2 2023

Aug 14, 2023

SELL
$1.05 - $1.63 $734,545 - $1.14 Million
-699,567 Reduced 8.46%
7,570,983 $8.56 Million
Q1 2023

May 15, 2023

BUY
$1.2 - $2.73 $1.12 Million - $2.55 Million
933,630 Added 12.73%
8,270,550 $11.2 Million
Q4 2022

Feb 14, 2023

BUY
$1.71 - $3.61 $1.05 Million - $2.22 Million
614,530 Added 9.14%
7,336,920 $13.6 Million
Q3 2022

Nov 15, 2022

BUY
$1.9 - $8.63 $2.32 Million - $10.5 Million
1,221,474 Added 22.2%
6,722,390 $16.5 Million
Q2 2022

Aug 15, 2022

BUY
$2.13 - $9.01 $2 Million - $8.47 Million
940,014 Added 20.61%
5,500,916 $13.4 Million
Q1 2022

May 16, 2022

SELL
$6.28 - $15.59 $17.2 Million - $42.7 Million
-2,735,763 Reduced 37.49%
4,560,902 $36.4 Million
Q4 2021

Feb 14, 2022

BUY
$14.7 - $28.67 $25.6 Million - $50 Million
1,743,471 Added 31.4%
7,296,665 $111 Million
Q3 2021

Nov 15, 2021

BUY
$24.31 - $33.6 $9.4 Million - $13 Million
386,623 Added 7.48%
5,553,194 $158 Million
Q2 2021

Aug 16, 2021

BUY
$26.09 - $40.4 $41.8 Million - $64.7 Million
1,602,496 Added 44.96%
5,166,571 $174 Million
Q1 2021

May 17, 2021

BUY
$33.06 - $56.93 $3.89 Million - $6.7 Million
117,701 Added 3.42%
3,564,075 $136 Million
Q4 2020

Feb 16, 2021

SELL
$39.09 - $57.4 $13.6 Million - $19.9 Million
-347,435 Reduced 9.16%
3,446,374 $144 Million
Q3 2020

Nov 10, 2020

SELL
$28.43 - $44.67 $52.1 Million - $81.8 Million
-1,832,207 Reduced 32.57%
3,793,809 $164 Million
Q2 2020

Aug 14, 2020

SELL
$11.71 - $30.29 $5.95 Million - $15.4 Million
-507,926 Reduced 8.28%
5,626,016 $170 Million
Q1 2020

May 11, 2020

BUY
$7.64 - $27.5 $46.9 Million - $169 Million
6,133,942 New
6,133,942 $83.9 Million

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.